Attenuated FOLFIRINOX in the salvage treatment of gemcitabine-refractory advanced pancreatic cancer: a phase II study

DOI: 10.1186/s40880-018-0304-1

Keywords: Attenuated FOLFIRINOX, Second-line, Pancreatic cancer, Gemcitabine

Full-Text   Cite this paper   Add to My Lib

Abstract:

Baseline demographic and clinical characteristics of 39 evaluated patients with gemcitabine-refractory advanced pancreatic cance

Full-Text